DM Individual Aggregator sells 50,709 shares of Dutch Bros
DM Individual Aggregator, LLC has sold over 50,000 shares of Dutch Bros Inc., signaling potential shifts in strategy for both companies.
Cannon Douglas A acquires 20,044 restricted stock units
Cannon Douglas A, President of AEP Transmission, acquires 20,044 restricted stock units, reflecting confidence in American Electric Power's future.
Wilczynski Patrick Reports Dividend Equivalent Units Transaction
Wilczynski Patrick's filing reveals a transaction involving dividend equivalent units at Sylvamo Corp, reflecting a commitment to rewarding executives.
Aeluma CFO Stewart Christopher P. Reports Stock Transaction
Aeluma, Inc.'s CFO Stewart Christopher P. reports stock transaction, reflecting ongoing activity in the semiconductor sector.
Korman Tyler Paz Amends Filing on Stock Ownership Details
Korman Tyler Paz amends a filing to correct stock ownership details, impacting transparency for ExoZymes Inc. and the biological products industry.
DM Trust Aggregator sells 94,978 shares of Dutch Bros Inc.
DM Trust Aggregator, LLC reported a sale of 94,978 shares in Dutch Bros Inc., reflecting strategic portfolio management in the retail-eating industry.
Sylvamo Corp Director Reports Stock Transactions
Sylvamo Corp's director Christine S. Breves reports new stock transactions, reflecting the company's commitment to its compensation program.
Mastech Digital reports insider stock purchases by Shaw
Mastech Digital, Inc. reports significant stock purchases by Steven A. Shaw, indicating confidence in the company's future and the management consulting services industry.
Dai Kun Reports Share Transaction as CEO of Uxin Ltd
Dai Kun, CEO of Uxin Ltd, discloses a transaction involving 5,541 shares, emphasizing transparency in the services-business sector.
Travis Boersma sells shares of Dutch Bros amid trading plan
Travis Boersma sold nearly 95,000 shares of Dutch Bros Inc. as part of a pre-established trading plan, reflecting ongoing ownership management.
Schmitz Ronald D. awarded stock as KKR board member
Schmitz Ronald D. receives stock award for his role on KKR's Board, illustrating the firm's commitment to leadership compensation in the finance sector.
PDS Biotechnology grants stock options to director Wendel Bruce
PDS Biotechnology Corp reports stock option grant to director Wendel Bruce, emphasizing leadership incentives in the pharmaceutical preparations sector.
Vitas Healthcare CEO Acquires Stock Options in SEC Filing
Joel L. Wherley, CEO of Vitas Healthcare, reported a significant stock option acquisition in a recent SEC filing, reflecting ongoing trends in executive compensation.
Dai Kun Reports Transaction of 4,002 Shares in Uxin Ltd
Dai Kun, CEO of Uxin Ltd, discloses a transaction involving 4,002 shares, reflecting changes in ownership structure within the company.
Rozenberg Haine Yael sells 1,458 shares of Valens Semiconductor
Rozenberg Haine Yael reports sale of 1,458 shares in Valens Semiconductor, reflecting strategic investment moves in the semiconductor sector.
Mathews Darrell Lee Jr. Reports Stock Transactions at Bank7
Mathews Darrell Lee Jr. disclosed stock transactions, acquiring and selling shares of Bank7 Corp., reflecting strategic movements in the banking sector.
Hendrix sells 4,000 shares of Interface Inc. under plan
Daniel T. Hendrix sold 4,000 shares of Interface Inc. as part of a trading plan, reflecting ongoing activity in the carpets and rugs industry.
Sylvamo Corp board member reports stock transaction
Sylvamo Corp's board member Desmond Jeanmarie F. reports a transaction involving deferred stock units, reflecting leadership engagement in the paper mills sector.
Kuppusamy Karthik Reports Stock Transaction at Quest Diagnostics
Kuppusamy Karthik, SVP at Quest Diagnostics, reports a stock transaction involving 33 shares, highlighting executive engagement in the medical laboratory services sector.
Boundless Bio reports significant stock purchases by insiders
Boundless Bio, Inc. reveals recent stock purchases by major stakeholders, indicating strong investment interest in the pharmaceutical sector.